Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 12:11:5789-5796.
doi: 10.2147/OTT.S168444. eCollection 2018.

Association of GSTP1 and P16 promoter methylation with the risk of HBV-related hepatocellular carcinoma: a meta-analysis

Qin Li  1 , Cunliang Deng  1 , Ting Zhang  1 , Xiang Li  2
Affiliations

Association of GSTP1 and P16 promoter methylation with the risk of HBV-related hepatocellular carcinoma: a meta-analysis

Qin Li et al. Onco Targets Ther. .

Abstract

Background: Study on the relationship between glutathione-S-transferase Pi 1 (GSTP1) and P16 promoter region methylation and the risk of hepatitis B virus-related hepatocellular carcinoma (HBV-related HCC) has produced inconsistent results.

Objectives: To assess the correlation between GSTP1 and P16 promoter methylation frequency and HBV-related HCC susceptibility.

Methods: All relevant studies were identified by searching PubMed, Embase, Web of Science, and China National Knowledge Infrastructure literature databases before December, 2017. The OR and the corresponding 95% CI were calculated to investigate the risk of GSTP1 and P16 promoter methylation rate and HBV-related HCC. Sensitivity analysis was performed and publication bias was estimated using the Begg's and Egger's test.

Results: Our meta-analysis identified the relationships of GSTP1 (six studies including 213 HBV-related HCC tumor tissues) and P16 (nine studies with 287 HBV-related HCC tumor tissue) promoter methylation with HCC risk. Compared with normal liver tissue and cirrhosis, the pooled ORs of GSTP1 promoter region methylation in HBV-related HCC cancer tissues were 6.05 (95% CI =1.20-30.52) and 5.21 (95% CI =2.19-12.41), respectively. Compared with paracancerous tissue, normal liver tissue, cirrhosis, and chronic hepatitis B as controls, the pooled ORs of P16 promoter region methylation in HBV-related HCC cancer tissues were 7.18 (95% CI =2.31-22.33), 24.89 (95% CI =3.38-183.03), 5.92 (95% CI =1.78-19.68), and 12.12 (95% CI =0.75-196.50).

Conclusion: In summary, our meta-analysis found strong associations between GSTP1 and P16 gene promoter methylation and an increased HBV-related HCC susceptibility. Moreover, GSTP1 and P16 methylation in promoter region could obviously increase the risk of HBV-related HCC in patients with cirrhosis, indicating that these would be promising biomarkers for early clinical diagnosis of HBV-related HCC.

Keywords: GSTP1; Hepatitis B virus; P16; hepatocellular carcinoma; meta-analysis.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Flow diagram of search strategy and study selection for meta-analysis.
Figure 2
Figure 2
Forest plots of GSTP1 promoter region methylation and the risk of HBV-related HCC. Notes: (A) Neoplasm vs normal tissues; (B) neoplasm vs cirrhosis tissues. Each square represents an OR for each specific study, with square sizes proportional to the weight. Weights are from random-effects analysis. Abbreviations: GSTP1, glutathione-S-transferase Pi 1; HBV, hepatitis B virus; HCC, hepatocellular carcinoma.
Figure 3
Figure 3
Forest plots of P16 promoter region methylation and the risk of HBV-related HCC. Notes: (A) Neoplasm vs adjacent tissues; (B) neoplasm vs normal tissues; (C) neoplasm vs cirrhosis tissues; (D) neoplasm vs CHB tissues. Each square represents an OR for each specific study, with square sizes proportional to the weight. Weights are from random-effects analysis. Abbreviations: CHB, chronic hepatitis B; HBV, hepatitis B virus; HCC, hepatocellular carcinoma.
Figure 4
Figure 4
Begg’s funnel plot analysis for publication bias between GSTP1 methylation and HBV-related HCC susceptibility. Notes: (A) Neoplasm vs normal tissues; (B) neoplasm vs cirrhosis tissues. Abbreviations: GSTP1, glutathione-S-transferase Pi 1; HBV, hepatitis B virus; HCC, hepatocellular carcinoma.
Figure 5
Figure 5
Begg’s funnel plot analysis for publication bias between P16 methylation and HBV-related HCC susceptibility. Notes: (A) Neoplasm vs adjacent tissues; (B) neoplasm vs normal tissues; (C) neoplasm vs cirrhosis tissues; (D) neoplasm vs CHB tissues. Abbreviations: CHB, chronic hepatitis B; HBV, hepatitis B virus; HCC, hepatocellular carcinoma.
See this image and copyright information in PMC

References

    1. Li W, Li L, Han J, Wu H. Liver transplantation vs liver resection in patients with HBV-related hepatocellular carcinoma beyond Milan criterion: A meta-analysis. Clin Transplant. 2018;32(3):e13193. - PubMed
    1. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264–1273. - PMC - PubMed
    1. Mani SKK, Andrisani O. Hepatitis B virus-associated hepatocellular carcinoma and hepatic cancer stem cells. Genes. 2018;9(3):E137. - PMC - PubMed
    1. Ganem D, Prince AM. Hepatitis B virus infection – natural history and clinical consequences. N Engl J Med. 2004;350(11):1118–1129. - PubMed
    1. Tian Y, Yang W, Song J, Wu Y, Ni B. Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis. Mol Cell Biol. 2013;33(15):2810–2816. - PMC - PubMed